7 Apr 2017

Acquisition of own shares 

Read More
4 Apr 2017

 UCB and Q-State Biosciences Form Research Collaboration to Develop Novel Therapeutics for Genetic Subtypes of Epilepsy

Read More
1 Apr 2017

UCB AND AMGEN REPORT NEW DATA AT ENDO 2017 EXAMINING THE OPTION OF A SECOND COURSE OF TREATMENT WITH EVENITY™* (ROMOSOZUMAB) 

Read More
24 Mar 2017

UCB General Meeting on 27 April 2017

Read More
24 Mar 2017

Headline

Read More
22 Mar 2017

U.S. Patent and Trademark Office confirms validity of patent for UCB's Vimpat®

Read More
16 Mar 2017

Transparency notifications

Read More
10 Mar 2017

Transparency notification

Read More
10 Mar 2017

Acquisition of own shares

Read More
9 Mar 2017

Transparency notification

Read More
Subscribe to